Alkermes plc. vs Immunovant, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Alkermes plc. and Immunovant, Inc. are worth about the same: $6.7 B and $6.6 B (market caps of Oct 14, 2026 for Alkermes plc. and Oct 7, 2026 for Immunovant, Inc.).
- Alkermes plc. made a net profit of $242 M, while Immunovant, Inc. made a net loss of $506 M.
- Alkermes plc. employs more people: 2,050 against 70 at Immunovant, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Alkermes plc. ALKS · #2,908 in the world | Immunovant, Inc. IMVT · #2,921 in the world |
|---|---|---|
| Profile | ||
| Country | 🇮🇪 Ireland | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 1987 | 2018 |
| Size | ||
| Market cap | $6.7 B | $6.6 B |
| Revenue | $1.5 B | — |
| Net income | $242 M▲ best | $-506 M |
| Employees | 2,050 | 70 |
| Valuation | ||
| Price to sales | 3.8× | — |
| Price to book | 3.7× | 7.8× |
| Free cash flow yield | 7.2%▲ best | -6.1% |
| Profitability | ||
| Gross margin | 86.7% | — |
| Operating margin | 17.2% | — |
| Net margin | 16.4% | — |
| Return on equity | 14.7%▲ best | -64.8% |
| Return on invested capital | 14.7% | — |
| Growth | ||
| Revenue growth | -5.3% | — |
| Revenue growth, 3 years a year | 9.9% | — |
| Earnings per share growth | -34.1% | — |
| Financial strength | ||
| Debt to equity | 0.0× | — |
| Net debt to EBITDA | -1.4× | — |
| Cash | ||
| Free cash flow margin | 32.5% | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Alkermes plc. or Immunovant, Inc.?
Alkermes plc. and Immunovant, Inc. are worth about the same: $6.7 B and $6.6 B (market caps of Oct 14, 2026 for Alkermes plc. and Oct 7, 2026 for Immunovant, Inc.).
Which makes more money, Alkermes plc. or Immunovant, Inc.?
Alkermes plc. made a net profit of $242 M, while Immunovant, Inc. made a net loss of $506 M.
Which has more employees, Alkermes plc. or Immunovant, Inc.?
Alkermes plc. employs more people: 2,050 against 70 at Immunovant, Inc.